ACDRS 2026 Course

The Course emphasizes integrated product development that is science-based, efficient, economical, high quality, and rapid, leading to better and safer medical products for patients.

See how this rigorous, in-depth, comprehensive, and systematic immersion into modern medical product development, regulation, and market introduction can benefit your career by viewing testimonials from former ACDRS Course participants.

Dates and session themes

Jan 28, 2026

First day of instruction

Jan 28-30, 2026

Session 1

The Medical Product Development Enterprise: Past, Present, and Future Perspectives

Mar 11-13, 2026

Session 2

Learning Trials: From Discovery to First in Humans

Apr 8-10, 2026

Session 3

Learning and Confirming Trials: Finding and Confirming the Right Dose

May 20-22, 2026

Session 4

Statistics: Design, Analysis, and Interpretation of Clinical Trials

Sep 9-11, 2026

Session 5

Global Clinical Trials Authorization and Marketing Authorization Processes

Oct 21-23, 2026

Session 6

Integrated Product Development, Portfolio Management, Project Management, and Preparing for Transition to the Market
Oct 23, 2026

Last day of instruction
 

Examination

December 19, 2025

Cancellation deadline

This is a hybrid course with the option to attend in-person (in DC) or virtually (via Zoom) for three days of eight hours each day.

See the Course for topics and learning outcomes

Venue

University of California, Washington Center (UCDC), 1608 Rhode Island Ave NW, Washington, DC

Eligibility

You must:

  • have a higher university degree, such as MD, PharmD, PhD, Master’s, or JD (Applicants without terminal degrees but with extensive product development will be considered)

  • have a primary interest in medical product discovery, development, regulation, or related activity

  • have at least one year of work experience in medical product development

  • be qualified via standards and nominations by submitting a one-page curriculum vitae to [email protected] prior to or immediately following registration

This course is open to all who meet academic, professional, and interest criteria. UCSF does not use race, gender, sex, or other protected categories or proxies for protected categories in the selection process.

Register

Registration fee: $15,000.00

A discounted fee for a limited number of participants from academia and government is available, please contact [email protected].

Enrollment is limited. You are encouraged to register well in advance. In case of cancellation before December 19, 2025 the fee (less $500.00 for administrative expenses) will be returned. There will be no substitute registrants or refund on cancellations made after this date.

For additional details, see FAQ.

"Participating in the American Course on Drug Development and Regulatory Sciences was a truly enriching experience. The course's structured approach provided deep insights into drug development and the regulatory process. The engaging lectures, real-world case studies, and practical exercises made the learning experience both informative and hands-on. The opportunity to network with experts and peers was invaluable. Overall, this course significantly enhanced my understanding of certain aspects and has undoubtedly benefited my career. I highly recommend it to anyone looking to deepen their knowledge of the biopharmaceutical industry, drug development, and regulatory sciences."
—Joe Rappon, VP and Head of Pharma, Alcon